RESMED INC Earnings Per Share Disclosure
| 2025 | 2024 | 2023 | |||||||||||||||
| Numerator: | |||||||||||||||||
| Net income | $ | 1,400,723 | $ | 1,020,951 | $ | 897,556 | |||||||||||
| Denominator: | |||||||||||||||||
| Basic weighted-average common shares outstanding | 146,716 | 147,021 | 146,765 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
| Stock options and restricted stock units | 624 | 529 | 690 | ||||||||||||||
| Diluted weighted average shares | 147,340 | 147,550 | 147,455 | ||||||||||||||
| Basic earnings per share | $ | 9.55 | $ | 6.94 | $ | 6.12 | |||||||||||
| Diluted earnings per share | $ | 9.51 | $ | 6.92 | $ | 6.09 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Aug 8, 2025 | Showing above |
| 2024 | Aug 9, 2024 | |
| 2023 | Aug 11, 2023 | |
| 2022 | Aug 12, 2022 | |
| 2021 | Aug 17, 2021 | |
| 2020 | Aug 13, 2020 | |
| 2019 | Aug 8, 2019 | |
| 2018 | Aug 17, 2018 | |
| 2017 | Aug 4, 2017 | |
| 2016 | Aug 5, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.